SCHEMBL4563591

SCHEMBL4563591

NC(=O)OCCC1=NOc2ccccc2C=C1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
PKM P14618 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TRPA1 O75762 1/20 0.32
P2RX4 Q99571 1/20 0.32
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30
SCN4A P35499 1/20 0.30
SCN5A Q14524 1/20 0.30
SCN9A Q15858 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6190907 0.79 LMNA (0.34) LMNATRPA1TSHRMAPK1SCN4A
Hydrochloric Acid SCHEMBL8205122 0.77 LMNA (0.33) LMNATRPA1TSHRMAPK1SCN4A
Hydrochloric Acid SCHEMBL8206694 0.77 LMNA (0.33) LMNATRPA1TSHRMAPK1SCN4A
SCHEMBL28760203 0.76 TDP1 (0.32)
Oxalic Acid SCHEMBL8205203 0.75 MEN1 (0.32) LMNATRPA1TSHRMAPK1SCN4A
SCHEMBL5079126 0.74 AKR1B1 (0.38) LMNACYP1A2TSHR
SCHEMBL6188489 0.73 SMN1; SMN2 (0.41) LMNAPKMSMN1; SMN2NPSR1TSHR
SCHEMBL9933267 0.73 KDM4E (0.33)
SCHEMBL8205903 0.72 HSD17B10 (0.36) SMN1; SMN2NPSR1TRPA1P2RX4MAPK1
SCHEMBL7377317 0.70 TRPA1 (0.37) LMNATRPA1P2RX4TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784188-A4 FUSED TRIAZOLE DERIVATIVES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO INC (US) 2009-06-24 EP disclosed
EP-1784188-A2 FUSED TRIAZOLE DERIVATIVES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES Merck & Co., Inc. (US) 2007-05-16 EP disclosed
WO-2006023750-A2 FUSED TRIAZOLE DERIVATIVES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO., INC. (US) 2006-03-02 WO disclosed